Gene · 6311
Papers3,217
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,217
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mitochondrial DNA Haplogroups and Age at Onset of Spinocerebellar Ataxia Type 2: A Study in Indian Patients. | Ann Indian Acad Neurol | 2026 | 41693683 | PubTator, text mining | PubMed |
| Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxia. | Nat Commun | 2026 | 41690933 | PubTator, text mining | PubMed |
| Preimplantation Genetic Testing of Spinocerebellar Ataxia Type 2-Robust Tools for Direct and Indirect Detection of the ATXN2 CAG Repeat Expansion. | Int J Mol Sci | 2026 | 41683965 | PubTator, text mining | PubMed |
| Bioinformatic Analyses of the Ataxin-2 Family Since Algae Emphasize Its Small Isoforms, Large Chimerisms, and the Importance of Human Exon 1B as Target of Therapies to Prevent Neurodegeneration. | Int J Mol Sci | 2026 | 41683920 | PubTator, text mining | PubMed |
| Patient-reported Vision Quality-of-life in Parkinsonian Syndromes and Ataxias and Association with Clinical Oculomotor Findings. | medRxiv | 2026 | 41674594 | PubTator, text mining | PubMed |
| Complementarity of Long-Reads and Optical Mapping in Parkinson's Disease for Structural Variants. | Ann Clin Transl Neurol | 2026 | 41653029 | PubTator, text mining | PubMed |
| Expanding the Genetic Landscape of ATXN2 Variants: Insights From a Biallelic Trinucleotide Repeat Expansion in an Acadian Family. | Neurol Genet | 2026 | 41630926 | PubTator, text mining | PubMed |
| A comprehensive tandem repeat catalog of the human genome. | Nat Commun | 2026 | 41605898 | PubTator, text mining | PubMed |
| Hereditary Ataxias: From Pathogenesis and Clinical Features to Neuroimaging, Fluid, and Digital Biomarkers-A Scoping Review. | Int J Mol Sci | 2026 | 41596528 | PubTator, text mining | PubMed |
| A deep ensemble encoder network method for improved polygenic risk score prediction. | BioData Min | 2026 | 41580836 | PubTator, text mining | PubMed |
| Altered Glymphatic Network in Spinocerebellar Ataxia: a Multimodal MRI Study Within a Structure-Environment-Function Framework. | Cerebellum | 2026 | 41504997 | PubTator, text mining | PubMed |
| Biallelic CAG repeat expansion in the ATXN2 gene presenting with parkinsonism and spasticity. | Parkinsonism Relat Disord | 2026 | 41435787 | PubTator, text mining | PubMed |
| Valosin-Containing Protein as a therapeutic target in CAG repeat-driven Spinocerebellar ataxias: Integrative transcriptomic and computational insights. | Comput Biol Chem | 2026 | 41435767 | PubTator, text mining | PubMed |
| Novel and rare variants in amyotrophic lateral sclerosis genes identified in Malaysian patients. | Amyotroph Lateral Scler Frontotemporal Degener | 2026 | 41359433 | PubTator, text mining | PubMed |
| Correction to "Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions". | Ann Neurol | 2026 | 41277873 | PubTator, text mining | PubMed |
| Investigating the Shared Genetic Architecture of 3 Age-Related Ocular Disorders. | Ophthalmol Sci | 2026 | 41211298 | PubTator, text mining | PubMed |
| Unraveling the genetic landscape of ALS in Greece: identification of known and novel causative variants in a 353-patient cohort. | Amyotroph Lateral Scler Frontotemporal Degener | 2026 | 41196070 | PubTator, text mining | PubMed |
| Ataxin-2 as a candidate blood biomarker for estimating disease status in cases of suspected glioblastoma recurrence. | Brain Tumor Pathol | 2026 | 40982134 | PubTator, text mining | PubMed |
| Ubiquitin signatures on aggregating proteins in neurodegeneration. | Essays Biochem | 2025 | 41837791 | PubTator, text mining | PubMed |
| Coarse-grained mathematical models for studying mechanical properties of the DNA. | Biophys Rev | 2025 | 41613867 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6311/papers?page=4